Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medtronic (NY: MDT )

84.74 +0.63 (+0.75%)
Official Closing Price Updated: 7:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medtronic

< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
The 3 Best MedTech Stocks to Buy Now: May 2024
Explore the best MedTech stocks to buy now that are driven by AI's potential to revolutionize healthcare efficiency. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
If You Can Only Buy One Dividend Stock in May, It Better Be One of These 3 Names
These dividend stocks to buy each offer long-term growth opportunities with income generation in the meantime to offset volatility. 
Via InvestorPlace
Reliable Rewards: 7 Dividend Stocks to Count On in Any Market
With uncertainty clouding the market, investors can sleep a little easier at night with these reliable dividend stocks. 
Via InvestorPlace
Medtronic Stock Could Soar 29%, According to a Wall Street Analyst. Is the Dividend Champion a Buy Now?
The medical device manufacturer has raised its dividend payout for 47 consecutive years. 
Via The Motley Fool
Analyst Expectations For Medtronic's Future
Via Benzinga
Medtronic Unusual Options Activity
Via Benzinga
These Dividend Stocks Are an Investor's Best Friend
These two healthcare stocks are well-known for their top-tier dividend programs. 
Via The Motley Fool
Stock Market Hits A Wall Despite Booming Nvidia: Weekly Review
The Nasdaq and S&P 500 hit record highs, but fell back. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Medtronic Dips: Is Now the Time to Buy?
Medtronic had another stable quarter with FCF growth and healthy capital returns. Analysts Hold the stock and see it advancing 15% at the midpoint. 
Via MarketBeat
Medtronic (MDT) Q4 2024 Earnings Call Transcript
MDT earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Nvidia's 10% Leap Propels Tech Indexes To Record Highs; Blue Chips, Small Caps Slip: What's Driving Markets Thursday?
Strong earnings and revenue guidance from Nvidia sparked a tech stock surge, with Nasdaq 100 and S&P 500 hitting record highs. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Medtronic Stock Slumped Today
A 27x earnings valuation and single-digit growth rate means Medtronic stock is probably going down. 
Via The Motley Fool
Medtronic's Q4 Earnings: Medical Device Giant Clocks Strong Sales From Neurology Devices, Hikes Dividend
Medtronic reported Q4 2024 sales of $8.59 billion, with 0.5% reported and 5.4% organic revenue growth. Dividend increased to $0.70 per share. FY 2025 EPS guidance is $5.40-$5.50. 
Via Benzinga
MDT Stock Earnings: Medtronic Beats EPS, Beats Revenue for Q4 2024
MDT stock results show that Medtronic beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024. 
Via InvestorPlace
Wall Street Braces For Strong Open On Nvidia Cheer, But Traders Wary Of Key Data: Why This Analyst Sees More Market Bullishness Near-Term
Major U.S. 
Via Benzinga
7 Blue-Chip Stocks to Buy Now: May 2024
These blue-chip stocks to buy offer long-term price appreciation opportunities reinforced with undeniable stock stability. 
Via InvestorPlace
Investor Sentiment Falls Further After Fed Minutes, Dow Tumbles 200 Points
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Nvidia, BJ's Wholesale Club And 3 Stocks To Watch Heading Into Thursday
Via Benzinga
3 Healthcare Stocks to Buy Now: May 2024
Healthcare stocks can perform well during times of heightened inflation and economic uncertainty. These are three to buy today. 
Via InvestorPlace
Topics Economy
Exposures Interest Rates
Medtronic's Heart Catheter Achieves Safety And Efficacy Goals In Patients With Irregular Heartbeat
Medtronic's SPHERE Per-AF study results reveal the Sphere-9 Catheter's superior safety and efficacy in treating persistent atrial fibrillation compared to the Thermocool SmartTouch SF. The Sphere-9... 
Via Benzinga
WPF Holdings Appoints New CEO
MELBOURNE, FL - (NewMediaWire) - May 17, 2024 - WPF Holdings, Inc. (OTC PINK: WPFH) today announced the appointment of Angel Orrantia as President and Chief Executive Officer and as a member of the... 
Via TheNewswire.com
Topics Initial Public Offering
Exposures Securities Market
WPF Holdings Appoints New CEO
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering
Exposures Securities Market
Arecor Therapeutics reports strong 2023 results and outlines expanding product pipeline
Arecor Therapeutics PLC (AIM:AREC)C CEO Sarah Howell discusses the company's 2023 performance and future plans with Proactive's Stephen Gunnion. 
Via TheNewswire.com
Investing in 5G Stocks: Still an Opportunity
5G technology represents a foundational shift in how we connect and interact with technology, and provides opportunities for potential growth and innovation. 
Via MarketBeat
5 Companies Leading the Charge With Robotic Solutions
Recent AI innovations have aided and advanced robotics, which is reshaping industries by automating tasks and garnering a surge in global investments. 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
1 No-Brainer Growth Stock to Buy and Hold for 10 Years
This company's potential far outweighs its risks. 
Via The Motley Fool
Will Insulet's Monopoly Crumble? Appellate Court Ruling Signals Shift in Automated Insulin Delivery Systems Market
Latest on Insulet and its legal battle with EOFlow. Understand the impact of the appellate court's decision on market dynamics and Insulet's future. 
Via Benzinga
From Hype To Reality, AI Reshapes Pharmaceutical Industry Across Drug Discovery To Marketing - Stocks To Watch
Unlock the potential of AI in pharmaceuticals. With AI's help, the pharma industry could see $60B-$110B in annual economic value. Dive into the future of drug discovery and clinical development with... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
The Big Split: 3 Stock Spinoffs Are Coming. Should You Buy?
Stock spinoffs can unlock shareholder value but management sometimes uses them to get rid of unwanted, slow-growing businesses. 
Via InvestorPlace
Intuitive Surgical Builds On Its Robotic Surgery Prowess. But Challengers Are Coming.
As new robotic surgery systems loom, Intuitive Surgical investors await a "game-changer." 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.